期刊文献+

膀胱癌诊断治疗的新进展 被引量:3

下载PDF
导出
摘要 世界范围内,膀胱癌发病率居常见肿瘤的第9位,病死率居第13位[1]。考虑到膀胱癌的监视随访方案及大部分患者相对较长的生存时间,膀胱癌患者平均治疗费用居常见肿瘤的前列[2]。作为一个显著的公共健康问题,简要回顾近年来对不同分期膀胱癌在诊断治疗方面的新进展如下。
出处 《河北中医》 2011年第12期1899-1901,共3页 Hebei Journal of Traditional Chinese Medicine
  • 相关文献

参考文献31

  • 1Parkin DM. The global burden of urinary bladder cancer[ J]. Scand J Urol Nephrol Suppl,2008, ( 218 ) : 12 20.
  • 2Botteman MF, Pashos CL, Redaelli A, et al. The health economics of bladder cancer: a comprehensive review of the published literature [ J ]. Pharmacoeconomics, 2003,21(18):1315 1330.
  • 3Grossman HB, Gomella L, Fradet Y, et al. A phase n[, muhicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer [J]. J Urol,2007,178(1) :62 67.
  • 4Fradet Y, Grossman HB, Gomella L, et al. A comparison of hexaminolevulinate fluorescence eystoscopy and white light cystoseopy for the detection of carcinoma in situ in patients with bladder cancer : a phase 1, muhieenter study[ J]. J Urol, 2007,178(1) :68 73.
  • 5Denzinger S, Burger M, Walter B, et al. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5 aminolevulinic acid induced fluorescence diagnosis: 8 year results of prospective randomized study [ J ]. Urology, 2007,69(4) :675 679.
  • 6Denzinger S, Wieland WF, Otto W, et al. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high grade bladder cancer A long term follow up of a randomized study [ J ]. BJU Int,2008,.101(5) :566 569.
  • 7Hajdinjak T. UroVysion FISH test for detecting urothelial cancers : metaanalysis of diagnostic accuracy and comparison with urinary cytology testing [ J ]. Urol Oncol,2008,26(6) :646 651.
  • 8Sarosdy MF, Schellhammer P, Bokinsky G,et al. Clinical evaluation of a multi target fluorescent in situ hybridization assay for detection of bladder cancer [J]. J Urol, 2002, 168 (5) : 1950 1954.
  • 9Herr HW, Donat SM, Reuter VE. Management of low grade papillary bladder tumors [ J ]. J Urol, 2007,178 ( 4 ) : 1201 1205.
  • 10Sylvester ILl, van der Meijden AP, Oosterlinck W, et al. Predicting recur rence and progression in individual pa tients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trims [ J ]. Eur Urol, 2006,49 (3) :466 477.

二级参考文献14

共引文献22

同被引文献30

  • 1王田,邱学德,黄杰,刘乔保,肖民辉,杨晓华.茶多酚对膀胱肿瘤细胞端粒酶活性的影响[J].现代泌尿外科杂志,2005,10(6):314-316. 被引量:6
  • 2郭雪涛,崔明玉.多基因改变与膀胱肿瘤生物学行为的关系及相关性研究[J].包头医学院学报,2006,22(4):460-462. 被引量:1
  • 3陈辉,崔岩,乔忠杰,徐万海,赵丕显.动脉插管化疗配合膀胱灌注治疗复发性、多发性、表浅性膀胱癌[J].现代生物医学进展,2007,7(10):1528-1529. 被引量:5
  • 4Kohya N, Kitajima Y, Jiao W, et al. Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line:repression of MTS1/S100A4 gene expression[J]. Int J Cancer, 2003,104(1) : 44-53.
  • 5Moriyama-Kita M, Endo Y, Yonemura Y, et al. S100A4 reru- lates E-cadherin expression in oral squamous cell carcinoma [J]. Cancer Lett, 2005,230(2) : 211-218.
  • 6Salah Z, Aqeilan R, Huebner K. WWOX gene and gene product: tumor suppression through specific protein interactions[J]. Future Oncol, 2010,6 ( 2 ) : 249-259.
  • 7Bednarek AK, Laflin K J, Daniel RL, et al. WWOX, a novel WW domain-containing protein mapping to human chro- mosome 16q23. 3 24. 1, a region frequently affected in breast Cancer[J]. Cancer Res, 2000,60(8) : 2140-2145.
  • 8Bouteille N, Driouch K, Hage PE, et al. Inhibition of the Wnt/beta catenin pathway by the WWOX tumor suppres- sor protein[J]. Oncogene, 2009,28 ( 28 ) : 2569-2580.
  • 9Est6cio MR, Issa JP. Dissecting DNA hypermethylation in Cancer[J]. FEBS Lett, 2011,585 ( 13 ) 2078-2086.
  • 10Chung W;Bondaruk J,Jelinek J,et al. Detection of blad der Cancer using novel DNA methylation biomarkers in urine sediments [J]. Cancer Epidemiol Biomarkers Prey, 2011,20(7) .. 1483-1491.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部